Fall 2022 Vol. 12 Issue 03
-
From the Editor-in-Chief
Cancer and AgingCancer cells exploit an aging "infrastructure" to threaten life in those 60 and older.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Thriving as a SurvivorLearn to live well in the years after cancer treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
Nurture a Circle of SupportLeaning on others can help to make you a better caregiver.
by K.J. Bannan
-
Policy Matters
A Call to Eliminate InequitiesThe AACR Cancer Disparities Progress Report highlights the progress being made toward cancer health equity and stresses the need to address this complex public health issue.
by Lisa A. Newman, MD, MPH
-
Caught in the Middle
Adolescents and young adults diagnosed with cancer often lag behind children and older adults in benefiting from treatment advances and social support.
by Cameron Walker
-
Chemo or Not?
Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
by Kris Conner
-
Taking Stock of CAR T-Cell Therapy
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
-
Survivor Profile
A Recovery MindsetResearcher and esophageal cancer survivor Laurie Betts leans into past lessons learned, including the value of service to others, to get through cancer.
by Lindsey Konkel Neabore
-
Q&A
Stay Engaged in LifeJournalist Helen Epstein’s memoir provides a candid account of nurturing her passions during treatment, even as the world shuttered its doors during the pandemic.
by Marci A. Landsmann
-
Get Involved
The Power of PlayPediatric cancer survivor Eric Newman launched the Roc Solid Foundation, which builds playsets for children who have cancer.
by Thomas Celona
-
Facts and Stats
Rules for Healthy LivingUpdated guideline reinforces the role of plant-based foods and heart-pumping activities for cancer survivors.
by Thomas Celona
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin